| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0006-3223(00)00838-6 |
| P698 | PubMed publication ID | 10773178 |
| P2093 | author name string | Lavori PW | |
| P2860 | cites work | The continuing unethical use of placebo controls | Q28244803 |
| Improving informed consent in clinical trials: a duty to experiment | Q41649691 | ||
| Plans, designs, and analyses for clinical trials of anti-cocaine medications: where we are today. NIDA/VA/SU Working Group on Design and Analysis | Q41668614 | ||
| Long-term outcome of lithium prophylaxis in bipolar disorder: a 5-year prospective study of 402 patients at a lithium clinic | Q45220527 | ||
| A comparison of clozapine and haloperidol in hospitalized patients with refractory schizophrenia. Department of Veterans Affairs Cooperative Study Group on Clozapine in Refractory Schizophrenia. | Q45335249 | ||
| Clinical and prophylactic trials with assured new treatment for those at greater risk: I. A design proposal. | Q53624313 | ||
| Hazards of inference: the active control investigation | Q69535436 | ||
| Comparison of standard and low serum levels of lithium for maintenance treatment of bipolar disorder | Q69792600 | ||
| Drug therapy in the prevention of recurrences in unipolar and bipolar affective disorders. Report of the NIMH Collaborative Study Group comparing lithium carbonate, imipramine, and a lithium carbonate-imipramine combination | Q70504944 | ||
| Clinical and prophylactic trials with assured new treatment for those at greater risk: II. Examples | Q71077040 | ||
| Problems in interpreting active control equivalence trials | Q74790402 | ||
| P433 | issue | 8 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | placebo | Q269829 |
| P304 | page(s) | 717-723 | |
| P577 | publication date | 2000-04-01 | |
| P1433 | published in | Biological Psychiatry | Q4914961 |
| P1476 | title | Placebo control groups in randomized treatment trials: a statistician's perspective | |
| P478 | volume | 47 |
| Q35102974 | Benefits and burdens of placebos in psychiatric research |
| Q34335687 | Catching up on health outcomes: the Texas Medication Algorithm Project |
| Q22241101 | Cognitive-behavioral therapy for adult anxiety disorders: a meta-analysis of randomized placebo-controlled trials |
| Q36291530 | Emerging empirical evidence on the ethics of schizophrenia research |
| Q37076279 | Feasibility of reducing the duration of placebo-controlled trials in schizophrenia research |
| Q37382358 | Impact of referral source and study applicants' preference for randomly assigned service on research enrollment, service engagement, and evaluative outcomes. |
| Q37484869 | Preference in random assignment: implications for the interpretation of randomized trials |
| Q34091943 | The placebo response in social phobia |
| Q73693569 | The use of placebos in randomized clinical trials of mood disorders: well justified, but improvements in design are indicated |
| Q34969649 | Treatment research in bipolar disorder: issues and recommendations |
| Q34661439 | What have we learned about trial design from NIMH-funded pragmatic trials? |
| Q52939268 | [Ethical implications of placebo-controlled clinical trials for psychotropic drugs]. |
Search more.